Engineered nanoscale ceria is used as a diesel fuel catalyst. Little is known about its mammalian central nervous system effects. The objective of this paper is to characterize the biodistribution of a 5-nm citrate-stabilized ceria dispersion from blood into brain and its pro-or antioxidant effects. An~4% aqueous ceria dispersion was iv infused into rats (0, 100, and up to 250 mg/kg), which were terminated after 1 or 20 h. Ceria concentration, localization, and chemical speciation in the brain were assessed by inductively coupled plasma mass spectrometry, light and electron microscopy (EM), and electron energy loss spectroscopy (EELS). Pro-or antioxidative stress effects were assessed as protein carbonyls, 3-nitrotyrosine, and protein-bound 4-hydroxy-2-trans-nonenal in hippocampus, cortex, and cerebellum. Glutathione reductase, glutathione peroxidase, manganese superoxide dismutase, and catalase levels and activities were measured in hippocampus. Catalase levels and activities were also measured in cortex and cerebellum. Na fluorescein and horseradish peroxidase (HRP) were given iv as blood-brain barrier (BBB) integrity markers. Mortality was seen after administration of 175-250 mg ceria/kg. Twenty hours after infusion of 100 mg ceria/kg, brain HRP was marginally elevated. EM and EELS revealed mixed Ce(III) and Ce(IV) valence in the freshly synthesized ceria in vitro and in ceria agglomerates in the brain vascular compartment. Ceria was not seen in microvascular endothelial or brain cells. Ceria elevated catalase levels at 1 h and increased catalase activity at 20 h in hippocampus and decreased catalase activity at 1 h in cerebellum. Compared with a previously studied~30-nm ceria, this ceria was more toxic, was not seen in the brain, and produced little oxidative stress effect to the hippocampus and cerebellum. The results are contrary to the hypothesis that a smaller engineered nanomaterial would more readily permeate the BBB.
Nanotechnology presents opportunities in many fields; however, information about untoward effects has lagged far behind. Incomplete identification of engineered nanomaterial (ENM) hazards and management of risks from environmental and occupational exposures could lead to serious human health problems (Nel et al., 2006) and lack of public acceptance of ENM uses.
Many ENMs are composed primarily of metal oxides. Ceria (also known as CeO 2 , ceric oxide, Ce dioxide, Ce oxide, CAS #1306-38-3) was selected for the present studies to test the hypothesis that ENM distribution across the blood-brain barrier (BBB) into the brain and resultant effects inversely relates to their size. Ceria was chosen because (1) it is an insoluble metal oxide readily observed in situ by electron microscopy (EM), (2) it is redox reactive, (3) it can be manufactured in various sizes to assess the effect of size on distribution, and (4) it has multiple commercial applications. Major uses are as the diesel fuel catalyst Envirox from Oxonica Ltd, as a component of Platinum Plus(R), and generated during Eolys combustion (Health Effects Institute [HEI], 2001) , and in chemicomechanical planarization.
Nanoscale ceria was nominated by the National Institute of Environmental Health Sciences for toxicological consideration because of its widespread and expanding industrial uses, limited toxicity data, and lack of toxicological studies (Integrated Laboratory Systems, 2006) . The Organisation for Economic Cooperation and Development (OECD) Environment Directorate Disclaimer: None of the authors has a financial conflict of interest related to this research. included ceria on its priority list of nanomaterials in commerce or likely to enter into commerce in the near term for inclusion in a set of reference materials to support measurement, toxicology, and risk assessment (OECD, 2008) .
Exposure to ENMs may result in their distribution into the brain directly from the nasal cavity via uptake into the olfactory or trigeminal nerves (Oberdö rster et al., 2004) , across the blood-cerebrospinal fluid barrier at the choroid plexuses, or across the BBB, the major route of substance entry into the brain. The BBB is one of the most limiting mammalian membranes. To permeate it, ENMs might diffuse through the~4-nm-wide tight junctions between opposing endothelial cells lining the microvessels that perfuse the brain (Kniesel and Wolburg, 2000) or flux through the endothelial cells. The amount of ENM that reaches the brain following inhalation or iv exposure has been found to be quite low or not measurable. Only~0.2% of 15-and 80-nm iridium ENMs were distributed from the lung to the brain, presumably across the BBB (Semmler et al., 2004) . Following inhalation, 20-29-nm-diameter carbon particles were not detected in rat brain (Oberdö rster et al., 2002) , some 30-nm MnO 2 particles were found in several brain regions (Elder et al., 2006) , and some 37-nm carbon particles were found in the cerebrum and less in the cerebellum (Oberdö rster et al., 2004) . Two-and 20-nm gold ENMs, given iv to mice, were not found in the brain (Sadauskas et al., 2007) . In contrast, Sonavane et al. (2008) showed that 15-and 50-nm gold ENMs were able to cross the BBB and enter the brain. These studies reported metal content. None used EM or energy dispersive X-ray spectroscopy (EDX) to demonstrate that the metal or carbon in tissues was in the particulate form given to the subject. Based on the variable extent of brain entry of ENMs in previous reports and the lack of similar study of ceria ENM, there is a need to determine the influence of the physicochemical properties of ENM ceria, including its size, on its distribution across membranes, such as the BBB and brain cells, and the resultant effects on the brain.
Ceria ENMs have toxic effects associated with increased oxidative stress (Brunner et al., 2006; Thill et al., 2006) . However, numerous studies reported ceria ENM to be neuroprotective, suggesting that it has utility in medical disorders caused by reactive oxygen species (ROS) (Chen et al., 2006; Das et al., 2007; Schubert et al., 2006; Xia et al., 2008) . Many of these results were attributed to antioxidant effects caused by defects (vacancies) in the ENM lattice structure and/or cerium (Ce) ion redox cycling. All these studies of the oxidative stress of ENMs were conducted in cell culture.
Oxidative stress in biological systems results from an imbalance between ROS production and antioxidant levels (Butterfield and Stadtman, 1997) . Under physiological conditions, many ROS (superoxide radicals, nitric oxide [NO] , and hydrogen peroxide) are present at moderate levels. Approximately 1-2% of superoxide radicals produced in mitochondria leak out from the electron transport chain (Poon et al., 2004) .
Although superoxide radicals are not highly reactive or noxious to proteins, lipids, or DNA, they can give rise to highly toxic ROS by reacting with NO to form the highly reactive peroxynitrite anion. They can also be catalytically converted into hydrogen peroxide by superoxide dismutase (SOD). Hydrogen peroxide can yield the much more reactive hydroxyl radical (OH . ) by the Fenton reaction if not scavenged by catalase or glutathione peroxidase (GPx; Evans and Halliwell, 1999; Poon et al., 2004) . Thus, antioxidant enzyme dysfunction may lead to oxidative stress. The brain is particularly susceptible to oxidative stressinduced damage because of its (1) high oxygen consumption to maintain metabolism, (2) high content of polyunsaturated fatty acids with their oxidatively susceptible allylic hydrogen atoms, (3) relatively high concentration of iron and ascorbate to carry out the radical-generating Fenton reaction, and (4) relatively low concentration of antioxidants and antioxidant enzymes (Butterfield and Stadtman, 1997) . The glutathione (GSH) system is one of its major antioxidant defense systems. The GSH system includes GPx, which catalyzes hydrogen peroxide scavenging, and glutathione reductase (GR), which maintains the reduced form of GSH. Therefore, GPx and GR are important enzymes to maintain a healthy cellular redox environment (Schafer and Buettner, 2001) .
We have shown that iv administration of a commercial ceria ENM induced oxidative stress in rat brain (Yokel et al., 2009 ). However, this ENM was of larger size than advertised, tended to agglomerate, and had an unknown surface coating. In the current study, 5-nm ceria ENM was synthesized and characterized, and its toxic effects were determined in the cerebellum, cortex, and hippocampus. The cortex and hippocampus were selected based on their functional importance in executing higher memory functions, learning and memory. Based on our previous experience with other studies, the cerebellum was largely unaffected. Hence, we selected the cerebellum as a negative control (Castegna et al., 2002; Sultana et al., 2006) . In addition to measurement of oxidative stress parameters, the levels and activity of GPx, GR, SOD, and catalase were measured in the hippocampus and catalase was measured in the cortex and cerebellum to provide additional insight into the interaction of ceria ENM at the molecular level in the brain.
The objectives of the present research were (1) to test the hypothesis that the size of metal oxide ENMs inversely relates to their ability to cross the BBB and produce immediate (1 h) and later (20 h) pro-and/or antioxidant effects and histopathology in the brain using ceria as a model metal oxide ENM and (2) to conduct an initial assessment to define the no observable effect level and lowest observable effect level (LOEL) of a 5-nm ceria ENM. Toward these goals, the iv route was used to assess the potential for this ENM, after being absorbed by any route and entering systemic circulation, to distribute into the brain and produce effects. Quite large doses were initially studied to likely produce significant effects. Ceria ENM was synthesized using a hydrothermal method (Masui et al., 2002 ) that produces monodisperse nanoparticles directly in the reactor. Typically, a 20-ml aqueous mixture of 0.5M (0.01 mol) ceria chloride and 0.5M (0.01 mol) citric acid was added to 20 ml of 3M ammonium hydroxide. The latter was in excess of that needed for complete reaction of the cerium chloride to cerium hydroxide. After stirring for 24 h at 50°C, the solution was transferred into a Teflon-lined stainless steel bomb and heated at 80°C for 24 h to complete the reaction. The final aqueous dispersion was injected i.v. without any further treatment.
Ceria characterization. The physicochemical properties of the ceria ENM were determined in our laboratories. The morphology and crystallinity of the ceria were evaluated using a 200-keV field emission analytical transmission electron microscope (JEOL JEM-2010F, Tokyo, Japan) equipped with an Oxford energy dispersive X-ray spectrometer. The ceria dispersion was diluted by a factor of~1000 in water, and the transmission electron microscopy (TEM) lacey carbon grid was dipped into the liquid. The particle size distributions (PSDs) for each batch of as-synthesized ceria aqueous dispersion were determined using dynamic light scattering (DLS; 90Plus NanoParticle Size Distribution Analyzer; Brookhaven Instruments Corporation, Holtsville, NY). Ceria ENMs were recovered from the reaction medium as follows. The dispersion was centrifuged (31,000 3 g for 16 h) to generate a ceria pellet, and the supernatant was siphoned off, replaced by deionized ultrafiltered water, and resuspended. The centrifuging/washing cycle was repeated three times, and the recovered ceria pellet was air dried overnight to generate a powder sample for Brunauer, Emmett, Teller (BET) measurement. The surface area of the dried powder was determined using a BET surface area analyzer (Micromeritics Instrument Corporation, Norcross, GA). The ceria content of the dispersion, which was prepared with an intended concentration of 5% ceria, and the potential presence of contaminating elements/metals were determined by digestion of ceria dispersion samples (as described below) and analysis by inductively coupled plasma mass spectrometry (ICP-MS). We analyzed the digested stock suspension for 58 elements using a semiquantitative scan of the mass spectrum and compared the count rates for each m/z with the count rates for a solution prepared with the same concentration of ultrapure HNO 3 . The free cerium concentration was determined by introducing 0.9 ml of the dispersion into three Amicon Ultra-4 centrifugal 3000 molecular weight cutoff (equivalent to 0.9 nm pore size) filter devices and centrifugation at 3000 3 g for~3 min to obtain filtrate, which was analyzed for cerium by ICP-MS. Electron energy loss spectroscopy (EELS) was performed using a JEOL 2010F scanning transmission electron microscope (STEM) outfitted with an ultra high resolution pole piece, GATAN 2000 GIF (Pleasanton, CA), GATAN DigiScan II, Fischione HAADF STEM detector (Export, PA), and EmiSpec EsVision software (Tempe, AZ). STEM images were acquired using the high-resolution probe at 2 Å , and EELS was performed using the 0.2 Å probe, alpha of 20 mrad, and a beta of 6 mrad. EELS was used to determine the Ce(III):Ce(IV) ratio from the M5/M4 ionization edges. The influence of common ions (0.9% NaCl), 10% sucrose, and physiological temperature on the stability of this ceria ENM dispersion was illustrated by their effects on the PSDs. Zeta potential of the ceria dispersion as infused into the rat was estimated from electrophoretic mobility measurements using a Zetasizer nano ZS with a typical ceria concentration~0.02 wt% (Malvern Instruments, Worchestershire, UK). Because the particles had hydrodynamic diameters < 200 nm, the Hü ckel approximation was used to calculate zeta potential from electrophoretic mobility.
To simulate ceria agglomeration in vivo, 0.45 mg ceria ENM was added to 1.5 ml whole blood freshly collected from a rat, containing~30 U heparin/ml blood. This was gently stirred at 37°C for 1 h. The whole blood was centrifuged at 400 3 g for 3 min, and the plasma removed. Equal volumes of plasma and 4% formalin were gently mixed well by hand and refrigerated. Similarly, formalin (400 ll, 4%) was added to the erythrocytes, gently mixed well by hand, and refrigerated.
Animals. This study used 53 male Sprague-Dawley rats, weighing 324 ± 29 g (mean ± SD), that were housed individually prior to study in the University of Kentucky Division of Laboratory Animal Resources facility. Animal work was approved by the University of Kentucky Institutional Animal Care and Use Committee. The research was conducted in accordance with the Guiding Principles in the Use of Animals in Toxicology.
Ceria administration. Rats were prepared with two cannulae, surgically inserted into femoral veins, which terminated in the vena cava. The next day the unanesthetized rats were infused iv via the shorter cannula with ceria dispersion or water (controls) adjusted to pH 8. To compensate for the iv administration of a considerable volume of water or grossly hypotonic ceria dispersion, concurrent iv infusion of an equal volume and rate of 1.8% sodium chloride in water was delivered into the second, longer, cannula. Based on the intended concentration of the ceria in dispersion of 5%, it was infused at~0.6 ml/h. The 100, 175, and 250 mg/kg ceria doses were delivered over 1, 1.75, and 2.5 h, in total volumes of~0.6, 1.05, and 1.5 ml, respectively. In initial studies, five rats were infused with 250 mg ceria/kg and three with 175 mg ceria/kg. All demonstrated lethargy and/or mild respiratory distress; three died. One rat that received 100 mg ceria/kg and six controls showed no distress. Therefore, the test dose for this study was 100 mg ceria/kg. The rats were terminated 1 and 20 h after completion of the infusion to enable determination of acute and later effects of the ceria ENM on oxidative stress parameters and potentially initial translocation and/or clearance of the ceria ENM. Seven rats were infused with 0 and 11 rats with 100 mg ceria/kg and terminated 1.02 ± 0.04 h after completion of the infusion. Eight rats were infused with 0 and 12 rats with 100 mg ceria/kg and terminated 20.0 ± 0.1 h after completion of the infusion. Five minutes before termination, the rats were given BBB integrity markers described below, anesthetized with ketamine, and decapitated to enable rapid harvest of the brain. The brain, heart, spleen, liver, lung, and right kidney were weighed; samples of whole blood, brain cortex, spleen (medial tip), and liver (near tip of larger of the two bifurcated lobes) were collected for cerium determination; samples of hippocampus and cerebellar hemisphere, a cross section of the heart, spleen (medial from tip), liver (medial from tip), lung (near the tip of the median lobe), and a cross section of the kidney were collected in neutral buffered formalin for light microscopy and EM; and samples of hippocampus, cortex, and cerebellum were rapidly frozen in cryovials in liquid nitrogen for oxidative stress assessment.
Samples of brain cortex, blood, liver, and spleen were prepared and analyzed for Ce by ICP-MS (Agilent 7500cx, Santa Clara, CA) as previously described (Yokel et al., 2009) , which reported the method detection limit (MDL) of Ce in tissue to be 0.089 mg Ce/kg. Cerium concentrations below the MDL were reported as 50% of the MDL. The relative percent difference between four replicates of diluted solutions analyzed with these samples was 2% for 30-120 ng Ce/ml and 18% for 1.5 ng Ce/ml. Six acid/peroxidedigested samples containing blood, brain, or liver that had~0, 30, or 80-120 ng Ce/ml were spiked with added cerium, 25, 25, or 83 ng Ce/ml, respectively. The recovery of the added cerium ranged from 97 to 105%.
BBB integrity assessment. Five minutes before termination, the rat was given Na fluorescein (334 Da) and horseradish peroxidase (HRP;~44,400 Da) as small and large BBB permeability markers, respectively. These were given iv in saline over 40 s to deliver 6 mg Na fluorescein and 20 mg (3340 or 3820 units) type II HRP in 1 ml. Twenty-five minutes prior to the BBB marker infusion, the rat was given 5 mg/kg diphenhydramine ip to block the histamine response to HRP. Postmortem brain cortex was obtained to quantify fluorescein and HRP. Using an iv infusion of oleic acid to open the BBB, we have shown increased concentrations of Na fluorescein, HRP, and an~30-nm ceria ENM (Sigma-Aldrich #639648) in rat brain compared with rats given the oleic acid vehicle (Alazizi, Dan, Florence, and Yokel, unpublished results), demonstrating the ability of these markers to reveal an increased permeability of the BBB.
HARDAS ET AL.
Light and electron microscopic assessment. Coronal brain slices containing hippocampi were cut and immediately immersed in 4% buffered formalin fixative overnight and stored in PBS at 4°C. The isolated hippocampi were sliced further into 3 mm 3 pieces, dehydrated, and embedded in Araldite 502. One-micrometer-thick sections were cut and stained with toluidine blue for light microscopic screening and examination. Thin sections from selected blocks were collected on copper grids for TEM evaluation. Additional sections collected on carbon-coated grids were prepared for high-resolution transmission electron microscopy (HRTEM), STEM and EDX analyses.
Analysis with EELS was concurrently conducted of the freshly synthesized 5-nm ceria particles in vitro and in the brain of rats after its iv infusion. The M5 and M4 ceria edges at 883 and 901 Ev and their heights and edge splitting were determined as measures of Ce(III) and Ce(IV), respectively (Gilliss et al., 2005) .
Oxidative stress assessment, sample preparation. Hippocampal, cortical, and cerebellar samples from control and treated rat brain were rapidly obtained postmortem and frozen in liquid nitrogen. Each was individually homogenized using a 550 Sonic Dismembrator (Fisher Scientific) for 10-20 s on ice with one break in between. The homogenization buffer contained 0.32M sucrose, 0.125M Tris, 0.6mM MgCl 2 , and protease inhibitors (4 lg/ml leupeptin, 4 lg/ml pepstatin A, 5 lg/ml aprotinin, and 0.2mM PMSF) at pH 8.0. Total protein concentration was measured by the bicinchoninic acid method.
Oxidative stress parameters. Levels of the oxidative stress parameters protein carbonyl (PC), 3-nitrotyrosine (3NT), and protein-bound 4-hydroxy-2-trans-nonenal (HNE) were measured in control and treated hippocampus, cortex, and cerebellum homogenates using specific antibodies and slot blot techniques as described (Butterfield, 1997; Sultana et al., 2005) .
Western blot analysis. Immunoblotting (Western blotting) analysis was performed on hippocampal homogenates to determine the levels of GPx, GR, manganese superoxide dismutase (MnSOD), and catalase enzymes and on cortical and cerebellum homogenates to determine catalase levels. In brief, 75 lg of protein from each sample homogenate was loaded and separated by SDS-polyacrylamide gel electrophoresis. The separated proteins were transferred to a nitrocellulose membrane, and the desired enzyme bands identified using specific antibodies and quantified using Scion image software (Sultana et al., 2008) .
Enzyme activity assays. Enzyme activity assays for GPx, GR, SOD, and catalase in hippocampus and also catalase in cortex and cerebellum were performed separately, with commercially available kits from Cayman Chemical Company, Ann Arbor, MI. Each assay kit comes with the guidelines for preparation of homogenization buffers, assay buffers, sample buffers, and internal standards and also with some other necessary chemical or nonchemical supplies. Therefore, the manufacturer's instructions were followed to carry out the entire assay for each antioxidant enzyme. Briefly, for these three assays, 10 lg of sample was added to each well of a 96-well plate with assay buffer and the other specified reagents. In the case of the GR assay, the enzymatic reaction was initiated by addition of nicotinamide adenine dinucleotide phosphate (NADPH) solution, whereas in the GPx assay by addition of cumene hydroperoxide solution. For both assays, progression of the enzymatic reaction was monitored spectrophotometrically at 340 nm in terms of the rate of consumption of NADPH. In the SOD assay, xanthine oxidase was used as the reaction initiator, and the end point of the reaction was determined by reading the absorbance at 440-460 nm. For the catalase assay, hydrogen peroxide was the initiator and the end point of the reaction was determined by the absorbance reading at 540 nm.
Data and statistical analysis. The slot blot, Western blot, and enzyme activity assay results are presented as mean ± SE, whereas all the other results are presented as mean ± SD. Brain fluorescein and HRP concentrations were calculated for each rat that received ceria as a percentage of control rats. Grubb's test was used to identify outliers in the BBB permeability marker results. Student's unpaired t-test was used to evaluate the statistical significance of BBB permeability marker results, organ weights, and tissue cerium concentrations, with 95% confidence interval for slot blot, Western blot, and enzyme assay data.
RESULTS

Ceria Composition
Ten batches of ceria were prepared and analyzed for Ce content. Samples digested and analyzed by ICP-MS (Yokel et al., 2009 ) confirmed the ENM to be CeO 2 , with trace amounts of lanthanum (< 10 À5 wt%). Count rates for the other 57 elements were not higher than in the blank. The free cerium content was 11.6 ± 0.3%. HRTEM/HRSTEM showed that the ceria ENM was polyhedral shaped and crystalline, confirming its purity. The X-ray diffraction pattern showed the ceria to be highly crystalline. It was face centered cubic with corresponding Miller indices of the most common faces of (111), (210), and (200). Evaluation of a number of TEM images showed that the ceria had a number-average primary particle size of~5 nm (Fig. 1) . The ceria ENM surface area was 121 m 2 /g. Analysis of the ceria dispersion (digested in HNO 3 /H 2 O 2 ) by ICP-MS showed that the ceria content of the as-synthesized dispersion was 4.35 ± 0.20%. Therefore, the actual dose was~85 mg/kg, rather than the intended 100 mg/kg. The ceria level is not expressed in molarity as these are solid, colloidal particles and are essentially insoluble in water. Assuming monodisperse spheroids with D ¼ 5 nm and a specific gravity of 7.65 for crystalline ceria, the number density of the dispersion was~8.7 3 10 16 particle/ml.
Dispersion Properties
The citrate ion was found to be a stabilizing electrolyte for ceria nanoparticles. The hydrogen ion concentration of 10 batches of ceria dispersion ranged from pH 7.7-8. At pH below 7.0, the ceria agglomerated; therefore, it was maintained as an aqueous dispersion at pH 7.7-8. Zeta potential of the citrate-stabilized particles was À53 ± 7 mV at pH~7.35. In general, dispersions with absolute zeta potential values greater than 30-40 mV are expected to be stable and the stability of dispersion is better with higher zeta potential. The cerium concentration in samples taken from the top and bottom of two ceria dispersion samples that were undisturbed for > 2 months were within 2.5% of each other, demonstrating dispersion stability.
The PSD of a liquid dispersion can be reported using many choices of weighting factors (including diameter, surface area, volume, and intensity [the measurement made by the DLS instrument]). For toxicology studies, the diameter-based PSD relates to PSD determined by EM, and the volume-based PSD relates to the distribution of particle sizes in the dose (as volume is linked directly to weight and the dose delivered to the animal). Intensity, the default weight factor for much DLS software, weights the PSD based on the directly measured intensity of the scattered light. However, when multimodal distributions are present, intensity-based PSDs are a poor choice for the average particle size and an inappropriate choice for evaluating the fraction of material within the various sample peaks.
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As shown in Table 1 , the portion of the dose of unagglomerated 5-nm particles is 98 vol% for the as-synthesized particles. If no additional agglomeration occurred in the biological environment, this would be an appropriate description of the dose. However, each of these environmental changes reduces the fraction of unagglomerated 5-nm particles. Specifically, the 0.9% NaCl solution has 87% 5-nm particles. The sucrose solution shows two peaks that are much larger than 5 nm, i.e., all the samples have agglomerated. The solution at physiological temperature has 88% unagglomerated 5-nm particles. Table 1 reports the average particle size and sample fraction in the two bimodal peaks for the PSDs in Figure 2 . Each bimodal peak is fairly monodisperse, so the average particle size does not vary much from intensity, to volume, to numberbased weighting factors. However, the reported fraction of the sample in each peak is extremely sensitive to the selected weighting factor. For example, the particles in 0.9% NaCl solution in peak 2 contribute 91% of the intensity signal but only 13% of a volume-based PSD curve. For a number-based PSD curve, the peak 2 contribution would be less than 1% of the total, suggesting that it would be difficult to detect this agglomeration via EM. When the results in Figures 2a and 2d are expressed on a number frequency basis, the agglomerate peaks essentially disappear (Table 1) . This illustrates the importance of using volume-average data to describe the dose.
Electron microscopic examination of erythrocytes from blood that had been incubated with ceria for 1 h to which formalin was added showed some small ceria agglomerations (Fig. 3) . Electron-dense material was seen on the erythrocyte surface, which provided adhering surfaces, and as adjacent agglomerates. The latter are presumed to be associated with plasma protein of unknown composition.
In initial studies, two of the rats that received 250 mg ceria/kg died 15 and 50 min after the ceria infusion, demonstrating significant respiratory distress, fluid exudation from the nose, and seizures. One that received 175 mg ceria/kg died 1 h after the infusion, demonstrating fluid in its stomach and pleural cavity. Postmortem examination of the distressed rats often showed pulmonary hemorrhagic foci and extravasation into the surrounding parenchyma. Figure 4 shows one such lung.
There were no significant differences in organ weights between the ceria-infused and control groups except for the spleen, which weighed significantly more (0.73 ± 0.11 vs. 0.56 ± 0.16 g) in the treated versus control rats terminated at 20 h, by two-tailed unpaired t-test (p ¼ 0.0125). Table 2 shows cerium concentrations in blood, brain cortex, liver, and spleen 1 and 20 h after the ceria infusion. In contrast to the lack of significant ceria accumulation in the brain, considerable ceria was seen in the liver and spleen, as demonstrated by cerium analyses by ICP-MS (Table 2) and EM (Figs. 5 and 6 ).
In the mid-CA1 region of the hippocampus, arrays of pyramidal cells with prominent apical dendrites intermingled with the permeating capillary network. Light microscopy revealed occasional erythrocytes and other blood cell elements in the capillary. At the EM level, particular attention was paid to small capillaries where BBB components were best defined. Only rarely did we find electron-dense inclusions in the endothelial lining (Fig. 5) . No evidence of BBB tight junction opening was seen. Similarly, ceria particles were not found in astrocytes, adjacent pericytes, or surrounding neurites (Fig. 5) . Other areas examined included the cerebellum and paraventricular organs such as medium eminence. Again, no ceria particles were found. In contrast to the brain, electron-dense inclusions were observed in the liver, which were shown by EDX to include cerium (Fig. 6 ).
Grubb's test revealed two outliers in the HRP 20-h control group results. When removed, brain fluorescein and HRP results were as shown in Figure 7 .
HRTEM-EELS showed sharp intense M5 and M4 edges for both the as-synthesized 5-nm ceria and ceria agglomerates in brain vasculature (Fig. 8) . The M 5 /M 4 ionization edge ratios showed very similar valence reduction of Ce ions for both concentrations. This may reflect some local variations, such as surface regions versus bulk particle. The results indicate that the ceria was not significantly changed after its biodistribution. Measurement of oxidative stress parameters (PC, 3NT, and protein-bound HNE) in the hippocampus, cortex, and cerebellum of adult rat brain 1 and 20 h after administration of 100 mg/kg ceria ENM did not reveal any significant difference in control versus treated samples (Table 3 and Figs. 9 and 10). To better understand the antioxidant cellular response to ENM ceria, expression levels and activities of GR, GPx, MnSOD, and catalase were measured in the hippocampus. The levels of catalase were significantly increased 1 h after ceria infusion in the hippocampus. The protein levels for GR and GPx were not different in samples from treated rats 1 or 20 h after ceria infusion compared with controls (Table 3) . Similarly, there was no difference in MnSOD protein levels for control and 1-or 20-h samples (Table 3 and Fig. 11) .
Furthermore, consistent with the lack of change in other antioxidant enzymes, the enzyme activity of catalase did not change 1 h after ceria infusion but was significantly increased 20 h later in the hippocampus (Table 3) . On the other hand, there was no change in the activity of SOD or GR and GPx (Table 3) in the same region. Because catalase was altered in hippocampus, analysis of the levels and activity of this antioxidant enzyme were also investigated in cortex and cerebellum. The results demonstrated that catalase levels remain unaltered in both cortex and cerebellum. However, catalase activity was significantly (p < 0.05) decreased in the cerebellum after 1-h treatment of 5-nm ceria ENM.
DISCUSSION
The number-based mean ceria hydrodynamic diameter in suspension of~7 nm as determined by DLS was consistent with the primary particle geometric diameter determined from HRTEM imaging (Fig. 1) . Assuming that the ceria was monodisperse and had no internal porosity, the BET surface area measurements of 121 m 2 /g convert to primary particles of 6-7 nm in diameter. This ceria was polyhedral not ideal cubes. Although this ceria was not spherical, their hydrodynamic diameter was only slightly larger than the TEM geometric diameter, as expected given the presence of citrate on the surface. Furthermore, the~4 wt% ceria aqueous dispersion was transparent, no large aggregates were observed to sediment up to 1 month, and Ce concentrations in the upper and lower layers were nearly identical after > 2 months, indicating a stable dispersion. This ceria dispersion contained 11.6% free cerium. It is likely that any ceria dispersion prepared using this method is likely to contain some free cerium. Generally, centrifugation and/or washing procedures are used to separate free cerium ions from an as-synthesized dispersion. However, we found that after ceria ENM was forced down from dispersion, agglomeration and aggregation occurred, and it was almost impossible to re-disperse the ENM in water as uniformly as the as-synthesized dispersion. If we had conducted this procedure, the ceria ENM we would have studied would not have been 5 nm. Given that we saw no evidence of uptake into the brain or alterations in BBB integrity at 1 h, it appears that the free cerium did not contribute to any of the effects observed.
This 5-nm citrate-coated ceria was considerably more toxic than the previously tested 30-nm ceria with unknown surface coating (Sigma-Aldrich #639648) (Yokel et al., 2009) . No rats died after receiving as much as 750 mg/kg of the 30-nm commercial ceria, whereas some rats died after receipt of 175 or 250 mg/kg of this 5-nm ceria, which was infused at the same rate, apparently because of pulmonary toxicity. Particle agglomeration and subsequent pulmonary emboli, which are quite common following administration of highly concentrated ENM dispersions, might have contributed to this. 100 (n ¼ 12) 12 ± 9 (1 ± 1) 0.58 ± 0.15 (0.0046 ± 0.0011) 1007 ± 264 (51 ± 11) 2885 ± 882 (10 ± 3) a Based on blood volume of the rat of 7% body weight and brain, liver, and spleen ceria concentrations 3 organ weights.
b All values were below the MDL.
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The small agglomerations of ceria seen in blood after 1-h incubation in vitro suggest that similar agglomerations may form in vivo. These may have been recognized by the reticuloendothelial organs and then cleared from circulation. These agglomerations were considerably smaller than those seen after incubation of~30-nm ceria in blood for 1 h (Yokel et al., 2009 ) perhaps accounting for the longer circulation time of this 5-nm ceria (initial half-life after infusion~1 h, Yokel, Dan, Florence, Graham, Unrine, Grulke, and Wu, unpublished results) than the previously studied 30-nm ceria, which showed an initial half-life of clearance from blood of~7 min (Yokel et al., 2009) .
The brain Ce concentration 1 h after infusion of this 5-nm ceria (2.6 ± 0.9 lg/g) was greater than seen after administration of 50, 250, or 750 mg/kg of a commercial 30-nm ceria (0.087, 0.15, and 1.1 lg/g). In that study, we found ceria in the capillary lumen and in some of the adjacent astrocytes 1 and 20 h after its infusion (Yokel et al., 2009 ).
However, 20 h after infusion of 5-nm ceria in the current study, brain Ce was lower than after the commercial 30-nm ceria (0.6 ± 0.1 lg/g vs. 1.0, 3.4, and 7.4 lg/g) (Yokel et al., 2009) . It is likely that the ceria in the bulk brain samples reflects ceria in the vascular bed, which was 270 ± 79 lg/g at 1 h. The vascular volume of rat brain is 2% of the frontal cortex and 2.6% of gray matter (Ohno et al., 1978) . We did not wash out the blood from the brain prior to decapitation. The product of the cerium concentration in blood (mean ¼ 270 lg/g at 1 h) times the vascular volume of the brain (2%) can account for the Ce in the bulk brain samples (2.6 ± 0.9 lg/g). Therefore, based on Ce concentrations and extensive electron microscopic imaging of the brain, the brain Ce appears to have been largely limited to the vascular compartment.
This 5-nm ceria was detected in peripheral organs, including Kupffer cells along the sinusoidal surface and in some hepatocytes. However, in spite of multiple observations using light microscopy and EM, it was not observed in the hippocampal mid-CA1 region. It is possible that a small ceria residual escaped our observation. It was observed in the brain vascular compartment. The absence of ceria in hippocampal tissue was not anticipated. Given prior reports of brain entry of inert ENMs considerably larger than 5 nm, our inability to see 5-nm citrate-stabilized ceria in brain endothelial, neural, and glial cells was surprising. We saw no evidence for BBB penetration of this 5-nm citrate-coated ceria ENM.
When used as a catalyst in diesel fuel, ceria is added as~10-nm primary particles coated with a dispersant to facilitate its dispersion. The chemical species of cerium released from the tailpipe of vehicles were 20-nm cerium oxide and cerium particles incorporated into larger soot particles of varying size; the greatest numbers were 50-70 nm (HEI, 2001) . Our findings of no ceria in the BBB microvascular cells or the brain are consistent with the uptake of 14-to 100-nm citrate-stabilized gold ENM into HeLa cells, which peaked for 50 nm, and was~50% less for the 14-nm Au ENM (Chithrani et al., 2006) . Finally, surface functionalization may be important. It is possible that the CeO 2 particles in the present study experienced greater repulsion from the cell membrane (Goodman et al., 2004) than ceria ENM used in our previous study because of the relatively large negative zeta potential of the citrate-stabilized particles at physiological pH.
There was minimal evidence for adverse effect on the BBB of this ceria, consistent with the prior lack of effect on the BBB of a 30-nm ceria (Yokel et al., 2009 ) and lack of observed effect of~30-nm spherical ceria on human aortic endothelial cells in culture (Kennedy et al., 2009) . Given the lack of distribution into the brain and limited effects on the BBB and hippocampal oxidative stress end points after 100-mg ceria/kg, which was~50% of a lethal dose, it appears that the toxicity of this ceria was limited to peripheral organs.
The biological effects of ceria ENMs have been a topic of discrepancy as ceria exhibits pro-and antioxidant effects on biological systems. Ceria can undergo a Fenton-like reaction in the presence of H 2 O 2 to generate the hydroxyl radical (Heckert et al., 2008) , which can then damage cellular proteins, lipids, and DNA (Poon et al., 2004) .
No significant difference was found in the levels of the oxidative stress markers PC, 3NT, or protein-bound HNE in the hippocampus, cortex, and cerebellum or changes in GSHrelated enzymes studied in hippocampus of rat brain 1 or 20 h after ceria ENM infusion. The hippocampus is highly involved 100 ± 3 101 ± 3 100 ± 5 103 ± 3 Protein-bound HNE 100 ± 7 103 ± 6 100 ± 3 101 ± 3 The GSH antioxidant defense system GR level 100 ± 4 99± 13 100 ± 3 109 ± 7 GR activity 100 ± 7 93± 5 100 ± 6 106 ± 5 GPx levels 100 ± 3 97± 4 100 ± 2 102 ± 3 GPx activity 100 ± 21 97 ± 18 100 ± 13 77 ± 10 Antioxidant enzymes MnSOD level 100 ± 8 93± 8 100 ± 6 9 8± 9 SOD activity 100 ± 10 93 ± 8 100 ± 8 7 6± 5 Catalase level 100 ± 11 141 ± 10* 100 ± 4 9 1± 5 Catalase activity 100 ± 3 101 ± 5 100 ± 7 128 ± 7* (b) Cortex
Oxidative stress markers PCs 100 ± 3 102 ± 3 100 ± 6 102 ± 3 3NT 100 ± 3 104 ± 4 100 ± 6 9 7± 4 Protein-bound HNE 100 ± 16 110 ± 9 100 ± 4 106 ± 5 Antioxidant enzymes Catalase level 100 ± 4 104 ± 2 100 ± 7 109 ± 6 Catalase activity 100 ± 7 93± 4 100 ± 6 105 ± 2 (c) Cerebellum
Oxidative stress markers PCs 100 ± 3 102 ± 3 100 ± 5 8 5± 3 3NT 100 ± 4 104 ± 2 100 ± 1 9 8± 2 Protein-bound HNE 100 ± 7 103 ± 6 100 ± 4 104 ± 2 Antioxidant enzymes Catalase level 100 ± 6 105 ± 6 100 ± 10 91 ± 9 Catalase activity 100 ± 6 84± 3* 100 ± 8 104 ± 5
Note. Results for slot blot data are from 6 controls and 9 treated rats at 1 h and 8 controls and 12 treated rats at 20 h. Western blot and enzyme activity results are from 7 controls and 11 treated rats at 1 h and 8 controls and 12 treated rats at 20 h. Catalase activity and levels in cortex are from 6 controls and 7 treated rats at 1 h and 8 controls and 12 treated rats at 20 h. Catalase activity and levels in cerebellum are from 6 controls and 9 treated rats at 1 h and 8 controls and 12 treated rats at 20 h. All values are expressed as mean of percentage of controls ± SE, which were concurrently assayed. The control mean was normalized to 100%. There was a significant difference in the levels of catalase antioxidant enzyme in hippocampus after 1 h, in catalase activity in the hippocampus after 20 h, and in cerebellum after 1 h, when compared with their respective controls. in memory-related functions and is affected more than most brain regions in neurodegenerative diseases like Alzheimer's compared with other brain regions (Bains and Shaw, 1997; Butterfield, 1997) . In the previous investigation of a commercially produced ceria ENM, a significant increase in levels of protein-bound HNE from hippocampus was observed 20 h after infusion of the ENM, indicating vulnerability of this region to toxicity of ceria ENM (Yokel et al., 2009 ). In the same investigation, a significant decrease in the PC levels in the cerebellum was observed, which was not seen in the current study.
As there were no changes observed in oxidative stress markers, we investigated the biochemistry of proteins and enzymes at the cellular level in the hippocampus. The levels and activity of SOD, GR, and GPx did not show a significant difference 1 and 20 h after ceria treatment. The lack of effect of ceria ENM infusion on this enzyme system is supported by the absence of ceria ENM in the brain. However, in the hippocampus Western blot results did show a significant increase in the catalase level 1 h after ceria ENM infusion. Furthermore, catalase activity also significantly increased in the hippocampus 20 h after ceria treatment. These results show that catalase protein levels and activity increased at different time points. At present it is not clear why a direct correlation in levels and activity of enzyme is absent. However, based on the TEM results presented herein, an increased level and activity of catalase was unexpected. We speculate that although this ceria ENM had not entered the brain, it had oxidative stress effects in the vasculature that may cause change in catalase levels and activity as a cellular defense response. ENMs can affect cells without entering them (Bhabra et al., 2009) . In support of this speculation, it had been shown earlier that nano-ceria is an SOD mimetic, generating H 2 O 2 (Korsvik et al., 2007) . Because H 2 O 2 has high membrane permeability (Halliwell, 1992) , this molecule with zero dipole moment has the possibility of crossing the (Ahlemeyer et al., 2007) . Catalase is involved in reduction of H 2 O 2 -induced toxicity in astrocytes, whereas GPx is predominant for scavenging of H 2 O 2 in neurons (Desagher et al., 1996) . Therefore, increased catalase levels and activity may suggest a cellular defense response to a ceria ENMmediated increased H 2 O 2 production to maintain cellular homeostasis, although this notion remains speculative. To determine if catalase was affected in other brain region, its levels and activity were determined in cortex and cerebellum. Catalase levels were unaltered in cortex and cerebellum. However, catalase activity was significantly decreased after 1 h treatment of 5-nm ceria ENM. In the scope of this study, it is difficult to identify the reason behind differences in the antioxidant enzyme-catalase response to treatment of 5-nm ceria ENM in different brain regions, mainly the hippocampus and cerebellum. However, it is possible that the different cell types in the hippocampus and cerebellum contribute to these differences in catalase response to ENM.
A recent report identified some of the many reasons behind the difficulty of determining human health risk factors associated with ENMs and recognized the lack of agreement on the use of a proper set of methods to characterize ENMs in vitro and in vivo (Balbus et al., 2007) . It suggested development and employment of an algorithm consisting of three steps/tiers to advance the field of nanotoxicology: (1) physicochemical characterization, (2) absorption, distribution, metabolism, and excretion/translocation characterization, and (3) biochemical ENM analysis. We previously employed a three-tier analysis approach to investigate pro-or antioxidant effects of ceria on rat brain (Yokel et al., 2009 ). The present study followed the same algorithm and included additional measures of pro-or antioxidant activity, employing established in vivo toxicological testing methods. These included determination of translocation (one of the ''red'' tests for which test method development was considered a high-priority research need) and ROS generation, suggested by Balbus et al. (2007) to be conducted in Tier 1 testing.
CONCLUSIONS
The small (5-nm) citrate-coated ceria ENM of this study given iv at 100 mg/kg did not produce profound pro-or antioxidant effects in the brain 1 or 20 h later. This may be because of its lack of BBB penetration. In fact, our results suggest that in the brain, most of the ceria ENM was located on the luminal side of the BBB endothelial cells. The implications of this study are: (1) in contrast to our hypothesis, this welldefined and well-characterized small ceria ENM does not appear to cross the BBB, in marked contradistinction to commercial, 30-nm ceria ENM (Yokel et al., 2009 ); (2) under the conditions of this study, ceria does not produce significant oxidative stress or BBB alterations, from which we speculate that, again under the conditions of this study, no neurotoxicity occurs; and (3) the LOEL for this ceria ENM after its iv infusion appears to be~75 mg/kg, based on the few significant short-term effects among all the oxidative stress parameters and antioxidant levels and their activities tested. Given the quite large dose of 5-nm ceria ENM administered systemically and general lack of effects on the brain, these results show its low toxicity to the brain, suggesting that ceria provides an inert core ENM enabling the study of the effects of size, shape, and surface chemistry on the biodistribution, biotransformation, and neurotoxic or neuroprotective potential of metal oxide ENMs. However, from the present results it is difficult to predict the long-term effects of ceria ENM accumulation. 
